FDA Roundup: Novavax COVID-19 Vaccine, First Digital Therapeutic for GAD
Check out important updates from the FDA for the week of September 2.
Breaking Down Return Solutions’ Rx Returns Process with Jeremy Cundiff
Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.
Pharmacist-Led Interventions Improve Hypertension Outcomes in Remote Program
Findings were presented at the American Heart Association's Hypertension Scientific Sessions in Chicago, Illinois.
Is LTC Pharmacy Going Back to the Future?
Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.
Major Drug Distributors to Pay $300 Million in Opioid Epidemic Settlements
McKesson, Cardinal Health, and Cencora will share the settlement payment, resolving claims that the companies were significantly involved in fueling the US opioid epidemic.
FDA Clears First Digital Therapeutic for Treatment of Generalized Anxiety Disorder
DaylightRX from Big Health is a digital formulation of cognitive behavioral therapy and is available by prescription only.
